Sunitinib malate

Definition: Sunitinib, sold under the brand name Sutent, is an anti-cancer medication. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) in January 2006. source: Wikipedia

ID

426455008

ID date

14 Nov 2007

Previous ID

10816411000001100

Name

Sunitinib malate